Indacaterol Inhibits Tumor Cell Invasiveness and MMP-9 Expression by Suppressing IKK/NF-κB Activation |
Lee, Su Ui
(Natural Medicine Research Center)
Ahn, Kyung-Seop (Natural Medicine Research Center) Sung, Min Hee (Natural Medicine Research Center) Park, Ji-Won (Natural Medicine Research Center) Ryu, Hyung Won (Natural Medicine Research Center) Lee, Hyun-Jun (Targeted Medicine Research Center, Korea Research Institute of Bioscience and Biotechnology) Hong, Sung-Tae (Department of Biological Sciences, Korea Advanced Institute of Science and Technology) Oh, Sei-Ryang (Natural Medicine Research Center) |
1 | van der Molen, T., Postma, D.S., Turner, M.O., Jong, B.M., Malo, J.L., Chapman, K., Grossman, R., de Graaff, C.S., Riemersma, R.A., and Sears, M.R. (1997). Effects of the long acting beta agonist formoterol on asthma control in asthmatic patients using inhaled corticosteroids. The Netherlands and Canadian formoterol study investigators. Thorax 52, 535-539. DOI ScienceOn |
2 | Vestbo, J., Prescott, E., and Lange, P. (1996). Association of chronic mucus hypersecretion with FEV1 decline and chronic obstructive pulmonary disease morbidity. Copenhagen City heart study group. Am. J. Respir. Crit. Care Med. 153, 1530-1535. DOI ScienceOn |
3 | Watanabe, T., Jono, H., Han, J., Lim, D.J., and Li, J.D. (2004). Synergistic activation of NF-kappaB by nontypeable Haemophilus influenzae and tumor necrosis factor alpha. Proc. Natl. Acad. Sci. USA 101, 3563-3568. DOI ScienceOn |
4 | Welte, T. (2009). Optimising treatment for COPD--new strategies for combination therapy. Int. J. Clin. Pract. 63, 1136-1149. DOI ScienceOn |
5 | Witherow, D.S., Garrison, T.R., Miller, W.E., and Lefkowitz, R.J. (2004). beta-Arrestin inhibits NF-kappaB activity by means of its interaction with the NF-kappaB inhibitor IkappaBalpha. Proc. Natl. Acad. Sci. USA 101, 8603-8607. DOI ScienceOn |
6 | Lundblad, L.K., Thompson-Figueroa, J., Leclair, T., Sullivan, M.J., Poynter, M.E., Irvin, C.G., and Bates, J.H. (2005). Tumor necrosis factor-alpha overexpression in lung disease: a single cause behind a complex phenotype. Am. J. Respir. Crit. Care Med. 171, 1363-1370. DOI ScienceOn |
7 | Luttrell, L.M., and Lefkowitz, R.J. (2002). The role of beta-arrestins in the termination and transduction of G-protein-coupled receptor signals. J. Cell Sci. 115, 455-465. |
8 | Oh, D.Y., Talukdar, S., Bae, E.J., Imamura, T., Morinaga, H., Fan, W., Li, P., Lu, W.J., Watkins, S.M., and Olefsky, J.M. (2010). GPR120 is an omega-3 fatty acid receptor mediating potent antiinflammatory and insulin-sensitizing effects. Cell 142, 687-698. DOI ScienceOn |
9 | Matera, M.G., Calzetta, L., and Cazzola, M. (2010). TNF-alpha inhibitors in asthma and COPD: we must not throw the baby out with the bath water. Pulm. Pharmacol. Ther. 23, 121-128. DOI ScienceOn |
10 | Muroski, M.E., Roycik, M.D., Newcomer, R.G., Van den Steen, P.E., Opdenakker, G., Monroe, H.R., Sahab, Z.J., and Sang, Q.X. (2008). Matrix metalloproteinase-9/gelatinase B is a putative the rapeutic target of chronic obstructive pulmonary disease and multiple sclerosis. Curr. Pharm. Biotechnol. 9, 34-46. DOI |
11 | Sekine, Y., Katsura, H., Koh, E., Hiroshima, K., and Fujisawa, T. (2012). Early detection of COPD is important for lung cancer surveillance. Eur. Respir. J. 39, 1230-1240. DOI ScienceOn |
12 | Shenoy, S.K., and Lefkowitz, R.J. (2003). Multifaceted roles of betaarrestins in the regulation of seven-membrane-spanning receptor trafficking and signalling. Biochem. J. 375, 503-515. DOI ScienceOn |
13 | Tashkin, D.P., and Ferguson, G.T. (2013). Combination bronchodilator therapy in the management of chronic obstructive pulmonary disease. Respir. Res. 14, 49. DOI |
14 | Klein, G., Vellenga, E., Fraaije, M.W., Kamps, W.A., and de Bont, E.S. (2004). The possible role of matrix metalloproteinase (MMP)-2 and MMP-9 in cancer, e.g. acute leukemia. Crit. Rev. Oncol. Hematol. 50, 87-100. DOI ScienceOn |
15 | Ling, H., Zhang, Y., Ng, K.Y., and Chew, E.H. (2011). Pachymic acid impairs breast cancer cell invasion by suppressing nuclear factor-kappaB-dependent matrix metalloproteinase-9 expression. Breast Cancer Res. Treat. 126, 609-620. DOI |
16 | Lee, S.U., Choi, Y.H., Kim, Y.S., Park, S.J., Kwak, H.B., Min, Y.K., Kim, H.N., Lim, K.E., Choi, J.Y., Rhee, M., et al. (2010). Physcion-8-O-beta-D-glucopyranoside enhances the commitment of mouse mesenchymal progenitors into osteoblasts and their differentiation: Possible involvement of signaling pathways to activate BMP gene expression. J. Cell. Biochem. 109, 1148-1157. |
17 | Lee, S.U., In, H.J., Kwon, M.S., Park, B.O., Jo, M., Kim, M.O., Cho, S., Lee, S., Lee, H.J., Kwak, Y.S., et al. (2013). beta-Arrestin 2 mediates G protein-coupled receptor 43 signals to nuclear Factor-kappaB. Biol. Pharm. Bull. 36, 1754-1759. DOI ScienceOn |
18 | Lefkowitz, R.J., and Shenoy, S.K. (2005). Transduction of receptor signals by beta-arrestins. Science 308, 512-517. DOI ScienceOn |
19 | Loganathan, R.S., Stover, D.E., Shi, W., and Venkatraman, E. (2006). Prevalence of COPD in women compared to men around the time of diagnosis of primary lung cancer. Chest 129, 1305-1312. DOI ScienceOn |
20 | Lora, J.M., Zhang, D.M., Liao, S.M., Burwell, T., King, A.M., Barker, P.A., Singh, L., Keaveney, M., Morgenstern, J., Gutierrez-Ramos, J.C., et al. (2005). Tumor necrosis factor-alpha triggers mucus production in airway epithelium through an IkappaB kinase betadependent mechanism. J. Biol. Chem. 280, 36510-36517. DOI ScienceOn |
21 | Luan, B., Zhang, Z., Wu, Y., Kang, J., and Pei, G. (2005). Betaarrestin2 functions as a phosphorylation-regulated suppressor of UV-induced NF-kappaB activation. EMBO J. 24, 4237-4246. DOI ScienceOn |
22 | Edwards, M.R., Bartlett, N.W., Clarke, D., Birrell, M., Belvisi, M., and Johnston, S.L. (2009). Targeting the NF-kappaB pathway in asthma and chronic obstructive pulmonary disease. Pharmacol. Ther. 121, 1-13. DOI ScienceOn |
23 | Churg, A., Wang, R.D., Tai, H., Wang, X., Xie, C., and Wright, J.L. (2004). Tumor necrosis factor-alpha drives 70% of cigarette smoke-induced emphysema in the mouse. Am. J. Respir. Crit. Care Med. 170, 492-498. DOI ScienceOn |
24 | Churg, A., Wang, R., Wang, X., Onnervik, P.O., Thim, K., and Wright, J.L. (2007). Effect of an MMP-9/MMP-12 inhibitor on smokeinduced emphysema and airway remodelling in guinea pigs. Thorax 62, 706-713. DOI ScienceOn |
25 | Cullum, V.A., Farmer, J.B., Jack, D., and Levy, G.P. (1969). Salbutamol: a new, selective beta-adrenoceptive receptor stimulant. Br. J. Pharmacol. 35, 141-151. DOI ScienceOn |
26 | Finlay, G.A., Russell, K.J., McMahon, K.J., D'Arcy E, M., Masterson, J.B., FitzGerald, M.X., and O'Connor, C.M. (1997). Elevated levels of matrix metalloproteinases in bronchoalveolar lavage fluid of emphysematous patients. Thorax 52, 502-506. DOI ScienceOn |
27 | Gao, H., Sun, Y., Wu, Y., Luan, B., Wang, Y., Qu, B., and Pei, G. (2004). Identification of beta-arrestin2 as a G protein-coupled receptor-stimulated regulator of NF-kappaB pathways. Mol. Cell 14, 303-317. DOI ScienceOn |
28 | Ghosh, S., May, M.J., and Kopp, E.B. (1998). NF-kappa B and Rel proteins: evolutionarily conserved mediators of immune responses. Ann. Rev. Immunol. 16, 225-260. DOI ScienceOn |
29 | Hanania, N.A., Chapman, K.R., and Kesten, S. (1995). Adverse effects of inhaled corticosteroids. Am. J. Med. 98, 196-208. DOI ScienceOn |
30 | Johnson, M. (2006) Molecular mechanisms of beta(2)-adrenergic receptor function, response, and regulation. J. Allergy Clin. Immunol. 117, 18-24; quiz 25. DOI ScienceOn |
31 | Ball, D.I., Brittain, R.T., Coleman, R.A., Denyer, L.H., Jack, D., Johnson, M., Lunts, L.H., Nials, A.T., Sheldrick, K.E., and Skidmore, I.F. (1991). Salmeterol, a novel, long-acting beta 2-adrenoceptor agonist: characterization of pharmacological activity in vitro and in vivo. Br. J. Pharmacol. 104, 665-671. DOI ScienceOn |
32 | Barnes, P.J., and Pride, N.B. (1983). Dose-response curves to inhaled beta-adrenoceptor agonists in normal and asthmatic subjects. Br. J. Clin. Pharmacol. 15, 677-682. DOI ScienceOn |
33 | Donohue, J.F., Fogarty, C., Lotvall, J., Mahler, D.A., Worth, H., Yorgancioglu, A., Iqbal, A., Swales, J., Owen, R., Higgins, M., et al. (2010). Once-daily bronchodilators for chronic obstructive pulmonary disease: indacaterol versus tiotropium. Am. J. Respir. Crit. Care Med. 182, 155-162. DOI ScienceOn |
34 | Catley, M.C., Chivers, J.E., Holden, N.S., Barnes, P.J., and Newton, R. (2005). Validation of IKK beta as therapeutic target in airway inflammatory disease by adenoviral-mediated delivery of dominant-negative IKK beta to pulmonary epithelial cells. Br. J. Pharmacol. 145, 114-122. DOI ScienceOn |
35 | Chetty, A., Cao, G.J., Severgnini, M., Simon, A., Warburton, R., and Nielsen, H.C. (2008). Role of matrix metalloprotease-9 in hyperoxic injury in developing lung. Am. J. Physiol. Lung Cell. Mol. Physiol. 295, L584-592. DOI ScienceOn |
36 | Naline, E., Trifilieff, A., Fairhurst, R.A., Advenier, C., and Molimard, M. (2007). Effect of indacaterol, a novel long-acting beta2-agonist, on isolated human bronchi. Eur. Respir. J. 29, 575-581. DOI ScienceOn |
37 | Yorgancioglu, A. (2012). Indacaterol in chronic obstructive pulmonary disease: an update for clinicians. Ther. Adv. Chronic. Dis. 3, 25-36. DOI ScienceOn |